Regeneron Pharmaceuticals, Inc. faces Eylea revenue decline but shows growth potential with Dupixent & Libtayo. Click for more on REGN stock news.

Alnylam Pharmaceuticals ALNY focuses on developing novel therapeutics based on RNAi technology. The company’s pipeline of ...

Attorney Stuart Silverman says the First Circuit’s widening the divide on the False Claims Act’s causation standard adds to the need for the Supreme Court to weigh in.

"One of the approaches I used in my project was bridging western medicine and also traditional indigenous practices." ...

This was the stock's third consecutive day of losses.

Celestial discoveries: Paz won the $250,000 top prize for his research on detecting objects in the night sky. Using ...

The teen is the first student from Levittown's General Douglas MacArthur High School to be named a finalist in the ...

Lifeworks Advisors LLC increased its stake in Regeneron Pharmaceuticals by 31.5%, now holding 6,743 shares worth $4.8 million ...

HIGH SCHOOL SUPER JUDGING … Northwest Ohio will send two finalists to the 2025 Regeneron International Science and ...

This was the stock's second consecutive day of losses.

In an opinion that may complicate the U.S. Department of Justice’s (“DOJ”) efforts to enforce the False Claims Act (“FCA”), the U.S. Court of ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to ...